PRRT2 and prostate cancer: Gandellini et al. showed that PKCɛ is an important target of miR-205, and depletion of PKCɛ was associated with reversion of the aggressive prostate cancer cells to epithelial type as determined by increased E-cadherin expression and decreased cell motility [63].